CN102172375A - Traditional Chinese medicine for treating chronic hepatitis - Google Patents
Traditional Chinese medicine for treating chronic hepatitis Download PDFInfo
- Publication number
- CN102172375A CN102172375A CN201010612094XA CN201010612094A CN102172375A CN 102172375 A CN102172375 A CN 102172375A CN 201010612094X A CN201010612094X A CN 201010612094XA CN 201010612094 A CN201010612094 A CN 201010612094A CN 102172375 A CN102172375 A CN 102172375A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- chronic hepatitis
- blood
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 206010008909 Chronic Hepatitis Diseases 0.000 title claims abstract description 12
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 12
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 10
- 239000008280 blood Substances 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 13
- 208000002193 Pain Diseases 0.000 abstract description 9
- 230000036407 pain Effects 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 208000010643 digestive system disease Diseases 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract 1
- 241000092668 Artemisia capillaris Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000234609 Portulaca oleracea Species 0.000 abstract 1
- 235000001855 Portulaca oleracea Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000002775 capsule Substances 0.000 description 15
- 239000000843 powder Substances 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 11
- 239000000284 extract Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 241001529553 Scoparia <angiosperm> Species 0.000 description 5
- 230000002440 hepatic effect Effects 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 206010019668 Hepatic fibrosis Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- AXONCVPTTFHNOI-UHFFFAOYSA-N kairine Chemical compound C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000007560 sedimentation technique Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000009860 fuzheng jiedu Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating chronic hepatitis, belonging to the field of traditional Chinese medicines for treating digestive system diseases and aiming at realizing the purposes of good effect and fast action. The traditional Chinese medicine disclosed by the invention is prepared from the raw materials of purslane, bighead atractylodes rhizome, lucid ganoderma, pseudo-ginseng, salvia miltiorrhiza bunge, capillary artemisia, pericarpium citri reticulatae viride and the like, has the functions of strengthening the body resistance, tonifying qi and blood, clearing heat, detoxicating, promoting blood circulation, removing blood stasis and relieving pains, and has the advantages of obvious effect, definite therapeutic effect and fast action.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
The present field of Chinese medicines that is intended to treat chronic hepatitis, the deficiency of two aspects of existence: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that large quantities of chronic hepatitis patients are because of can not get the treatment of active drug, liver disease constantly develops, and clinical symptoms can not get alleviating, and the patient is seriously weak for a long time, dull pain in liver, liver function decline, hepatic fibrosis etc., life quality descends greatly, and I and family members are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of chronic hepatitis, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of chronic hepatitis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Portulacae 5-15 part Rhizoma Atractylodis Macrocephalae 5-15 part Ganoderma 6-18 part
Radix Notoginseng 3-9 part Radix Salviae Miltiorrhizae 6-18 part Herba Artemisiae Scopariae 6-18 part
Pericarpium Citri Reticulatae Viride 5-15 part
The Chinese medicine of this treatment chronic hepatitis is made by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is as follows: Ganoderma is broken into graininess, cross 40 mesh sieves →, concentrate → mixed, leave standstill 10-12 hour, centrifugal → as to add 75% ethanol with 95% ethanol of 3 times of volumes with 1: 20 hot water (95 ℃) lixiviate → lixiviating solution decompression, precipitate polysaccharide → dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Herba Portulacae, the Rhizoma Atractylodis Macrocephalae, Radix Salviae Miltiorrhizae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride are extracted through conventional water extraction process, make extract extractum fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, make Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We think that the main diseases of chronic hepatitis B is because of being the heresy of epidemic disease poison at research.Be patient's hypoimmunity, cause viral infection, outbreak inflammation, state of an illness delay, obstinate.Though under present technical conditions, still virus can't be driven away fully externally, remove totally, we can suppress it by enhancing human body immunity power, and the control virus replication reduces viral load, and this is the key of treatment primary disease.So we attach most importance to Fuzheng Jiedu, benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling is taken good care of the liver spleen, Qinghua hot and humid ecchymosis.The value of maximum of the present invention just is: it has captured difficult two " difficult problems " that heal of delay in the chronic hepatitis treatment---and the one, " dull pain in liver " that is difficult to overcome significantly alleviated even disappeared, and the 2nd, insoluble " hepatic fibrosis reverse " realizes substantially or fully.This is that doctor and patient call expectation hope for many years again and again.Ganoderma, Rhizoma Atractylodis Macrocephalae the body resistance strengthening and constitution consolidating among the we, benefiting QI and nourishing blood, the pivotal role of outstanding immunity, the easing the affected liver nourishing the liver, the spleen invigorating activating the spleen, enhancing human body immunity power, " opposing " interaction energy of immunity effectively resists hepatitis B virus duplicating in vivo, reduces its quantity; Radix Salviae Miltiorrhizae, Radix Notoginseng passage, nourishing blood, promoting blood circulation, removing blood stasis and relieving pain is enriched blood with nourishing the liver and kidney, removes the stagnant heat of blood part, and " reparation " effect of immunity can be repaired impaired hepatic tissue and liver function; Be aided with the soothing the liver dispelling the stagnated QI of Pericarpium Citri Reticulatae Viride, rush down pain relieving clearly, to separate dull pain in liver; The Herba Portulacae heat-clearing and toxic substances removing, removing heat from blood, antibiotic; The soothing the liver heat clearing away of Herba Artemisiae Scopariae, eliminating damp, detoxifying is removed the damp and hot evil poison of bridle for a long time.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and heat-clearing and toxic substances removing, the merit of promoting blood circulation, removing blood stasis and relieving pain, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Herba Portulacae 60 gram Rhizoma Atractylodis Macrocephalaes 60 kairine sesames 70 grams
Radix Notoginseng 30 gram Radix Salviae Miltiorrhizaes 70 gram Herba Artemisiae Scopariaes 70 grams
Pericarpium Citri Reticulatae Viride 60 grams
Weight is extracted Ganoderma with decoction and alcohol sedimentation technique in accordance with regulations; With conventional water extraction process Herba Portulacae, the Rhizoma Atractylodis Macrocephalae, Radix Salviae Miltiorrhizae, Herba Artemisiae Scopariae, Pericarpium Citri Reticulatae Viride are extracted, make extract fine powder 78 grams altogether, Radix Notoginseng is ground into fine powder, mix with said extracted thing fine powder, stir, make fine particle, the capsule of packing into No. 0, make 385 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight in grams is a unit):
The Herba Portulacae 90 gram Rhizoma Atractylodis Macrocephalaes 90 kairine sesames 120 grams
Radix Notoginseng 50 gram Radix Salviae Miltiorrhizaes 120 gram Herba Artemisiae Scopariaes 120 grams
Pericarpium Citri Reticulatae Viride 90 grams
By above-mentioned same method, make 628 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Herba Portulacae 150 gram Rhizoma Atractylodis Macrocephalaes 150 kairine sesames 180 grams
Radix Notoginseng 80 gram Radix Salviae Miltiorrhizaes 180 gram Herba Artemisiae Scopariaes 180 grams
Pericarpium Citri Reticulatae Viride 150 grams
By above-mentioned same method, make 992 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
9 parts of 7 portions of Ganodermas of 7 parts of Rhizoma Atractylodis Macrocephalaes of Herba Portulacae
9 parts of 9 portions of Herba Artemisiae Scopariaes of 4 parts of Radix Salviae Miltiorrhizaes of Radix Notoginseng
7 parts on Pericarpium Citri Reticulatae Viride
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
16 parts of 12 portions of Ganodermas of 12 parts of Rhizoma Atractylodis Macrocephalaes of Herba Portulacae
16 parts of 16 portions of Herba Artemisiae Scopariaes of 7 parts of Radix Salviae Miltiorrhizaes of Radix Notoginseng
12 parts on Pericarpium Citri Reticulatae Viride
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science chronic hepatitis, through 8 routine clinical observations.Selecting the tcm diagnosis chronic hepatitis is standard: limb is soft weak, and is weak from head to foot; Poor appetite, abdominal distention, dyspepsia; Face is pitch-dark, hepatic face is arranged; Dull pain in liver; Hepatic fibrosis is serious; It is undesired that liver function transaminase continues, and other index such as plasma albumin, blood total bilirubin etc. are unusual.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 4 examples, women's 4 examples do not have other serious disease, and the age is 51 years old-77 years old, 63.6 years old mean age.
Efficacy determination:
1, produce effects: weak alleviation, on one's body energetically; Poor appetite, abdominal distention, dull pain in liver are obviously alleviated, and the hepatic region is comfortable; Hepatic face is taken on a new look to some extent, and it is pale that face becomes; The hepatic fibrosis inspection is obviously alleviated; Indexs such as liver function test transaminase, plasma albumin are obviously improved.
2, effective: weak solution, on one's body energetically, abdominal distention, poor appetite, hepatic face are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 6 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.8 philtrums of clinical experiment, produce effects 4 people, effective 3 people, invalid 1 people, total effective rate 87.5%.
Claims (1)
1. Chinese medicine for the treatment of chronic hepatitis, it is characterized in that: it is to make with the component of following weight ratio: Herba Portulacae 5-15 part, Rhizoma Atractylodis Macrocephalae 5-15 part, Ganoderma 6-18 part, Radix Notoginseng 3-9 part, Radix Salviae Miltiorrhizae 6-18 part, Herba Artemisiae Scopariae 6-18 part, Pericarpium Citri Reticulatae Viride 5-15 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010612094XA CN102172375A (en) | 2010-12-20 | 2010-12-20 | Traditional Chinese medicine for treating chronic hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010612094XA CN102172375A (en) | 2010-12-20 | 2010-12-20 | Traditional Chinese medicine for treating chronic hepatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102172375A true CN102172375A (en) | 2011-09-07 |
Family
ID=44515750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010612094XA Pending CN102172375A (en) | 2010-12-20 | 2010-12-20 | Traditional Chinese medicine for treating chronic hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102172375A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102626457A (en) * | 2012-04-20 | 2012-08-08 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
| CN102670872A (en) * | 2012-06-07 | 2012-09-19 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
| CN103392960A (en) * | 2012-08-22 | 2013-11-20 | 谢美云 | Medicinal and edible dual-purpose health care product for protecting chemical liver damage and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843694A (en) * | 2009-09-25 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating chronic hepatitis |
-
2010
- 2010-12-20 CN CN201010612094XA patent/CN102172375A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843694A (en) * | 2009-09-25 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating chronic hepatitis |
Non-Patent Citations (1)
| Title |
|---|
| 王维伟，陈建杰: "陈建杰善用苍白二术从湿论治慢乙肝经验", 《辽宁中医杂志》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102626457A (en) * | 2012-04-20 | 2012-08-08 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
| CN102670872A (en) * | 2012-06-07 | 2012-09-19 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic hepatitis |
| CN103392960A (en) * | 2012-08-22 | 2013-11-20 | 谢美云 | Medicinal and edible dual-purpose health care product for protecting chemical liver damage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843694B (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102389480A (en) | Chinese medicament for treating hepatitis | |
| CN102379989A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101953924A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102327358A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102379947A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102172375A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102091165A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101991685A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101953925A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102389479A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102068533A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101979023A (en) | Chinese medicine for curing chronic hepatitis | |
| CN102379994A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102172369A (en) | Chinese medicine for treating hepatocirrhosis | |
| CN101979006A (en) | Chinese medicament for treating chronic hepatitis | |
| CN102138995A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101972330A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102048873A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN102389542A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN102114190A (en) | Chinese medicine for treating diabetic constipation | |
| CN102114109A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101843750B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843756B (en) | Chinese medicament for treating chronic nephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110907 |